Miranda Kleijn

975 total citations
24 papers, 788 citations indexed

About

Miranda Kleijn is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Miranda Kleijn has authored 24 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Immunology. Recurrent topics in Miranda Kleijn's work include PI3K/AKT/mTOR signaling in cancer (10 papers), Polyamine Metabolism and Applications (6 papers) and Protein Kinase Regulation and GTPase Signaling (5 papers). Miranda Kleijn is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (10 papers), Polyamine Metabolism and Applications (6 papers) and Protein Kinase Regulation and GTPase Signaling (5 papers). Miranda Kleijn collaborates with scholars based in Netherlands, United Kingdom and United States. Miranda Kleijn's co-authors include Christopher G. Proud, Gert C. Scheper, Harry O. Voorma, Nick Morrice, Adri A.M. Thomas, Carlos L.J. Vrins, Gavin I. Welsh, Roel van Wijk, Ian D. Fisk and Moira A. Taylor and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Miranda Kleijn

24 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miranda Kleijn Netherlands 15 597 101 88 70 62 24 788
Ziyou Cui United States 17 551 0.9× 76 0.8× 65 0.7× 135 1.9× 44 0.7× 26 782
Gerard C.M. van der Zon Netherlands 15 648 1.1× 116 1.1× 92 1.0× 111 1.6× 55 0.9× 32 972
Maria Buxadé Spain 11 500 0.8× 116 1.1× 209 2.4× 93 1.3× 84 1.4× 14 805
Jae Ryoung Hwang South Korea 16 686 1.1× 112 1.1× 116 1.3× 95 1.4× 104 1.7× 33 975
Yoon Ha Choi South Korea 17 466 0.8× 96 1.0× 143 1.6× 109 1.6× 69 1.1× 29 780
Valentina Iadevaia United Kingdom 19 879 1.5× 124 1.2× 90 1.0× 85 1.2× 130 2.1× 31 1.2k
Xianming Kong United States 6 830 1.4× 112 1.1× 70 0.8× 80 1.1× 56 0.9× 6 984
Daniel DiSepio United States 11 431 0.7× 87 0.9× 140 1.6× 75 1.1× 79 1.3× 14 744
Sabine Wolter Germany 15 479 0.8× 44 0.4× 129 1.5× 84 1.2× 99 1.6× 29 753
J. Guhaniyogi United States 5 546 0.9× 35 0.3× 87 1.0× 67 1.0× 89 1.4× 5 697

Countries citing papers authored by Miranda Kleijn

Since Specialization
Citations

This map shows the geographic impact of Miranda Kleijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miranda Kleijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miranda Kleijn more than expected).

Fields of papers citing papers by Miranda Kleijn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miranda Kleijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miranda Kleijn. The network helps show where Miranda Kleijn may publish in the future.

Co-authorship network of co-authors of Miranda Kleijn

This figure shows the co-authorship network connecting the top 25 collaborators of Miranda Kleijn. A scholar is included among the top collaborators of Miranda Kleijn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miranda Kleijn. Miranda Kleijn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Veer, Laura van ‘t, Elma Meershoek‐Klein Kranenbarg, Marjolijn Duijm‐de Carpentier, et al.. (2024). Selection of Patients With Early-Stage Breast Cancer for Extended Endocrine Therapy. JAMA Network Open. 7(11). e2447530–e2447530. 1 indexed citations
2.
Liefers, Gerrit‐Jan, Elma Meershoek‐Klein Kranenbarg, Marjolijn Duijm‐de Carpentier, et al.. (2023). Abstract GS5-10: Utility of the 70-gene MammaPrint test for prediction of extended endocrine therapy benefit in patients with early-stage breast cancer in the IDEAL Trial. Cancer Research. 83(5_Supplement). GS5–10. 6 indexed citations
3.
Liefaard, Marte C., Anna van der Voort, Mette S. van Ramshorst, et al.. (2023). BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer. Breast Cancer Research. 25(1). 71–71. 3 indexed citations
4.
Liefaard, Marte C., Rajith Bhaskaran, Anke Witteveen, et al.. (2022). 161P MammaPrint and BluePrint diagnostic tests can be robustly assessed on Whole-Transcriptome NGS platform. Annals of Oncology. 33. S612–S612. 1 indexed citations
5.
6.
Kleijn, Miranda, et al.. (2022). Factors Affecting Adherence, Intake, and Perceived Palatability of Oral Nutritional Supplements: A Literature Review. The journal of nutrition health & aging. 26(7). 663–674. 33 indexed citations
7.
Noordhoek, Iris, Esther Bastiaannet, Laura J. Esserman, et al.. (2022). Validation of the 70-gene signature test (MammaPrint) to identify patients with breast cancer aged ≥ 70 years with ultralow risk of distant recurrence: A population-based cohort study. Journal of Geriatric Oncology. 13(8). 1172–1177. 9 indexed citations
8.
Cornacchia, Leonardo, et al.. (2021). The relation between stimulated salivary flow and the temporal consumption experience of a liquid oral nutritional supplement. Appetite. 166. 105325–105325. 10 indexed citations
9.
Terpstra, Fokke G., Miranda Kleijn, Anky H. L. Koenderman, et al.. (2006). Viral safety of C1-inhibitor NF. Biologicals. 35(3). 173–181. 33 indexed citations
10.
Kleijn, Miranda & Christopher G. Proud. (2002). The regulation of protein synthesis and translation factors by CD3 and CD28 in human primary T lymphocytes. BMC Biochemistry. 3(1). 11–11. 15 indexed citations
11.
Méndez, Raúl, Gavin I. Welsh, Miranda Kleijn, et al.. (2001). Regulation of Protein Synthesis by Insulin Through IRS-1. Progress in molecular and subcellular biology. 26. 49–93. 8 indexed citations
12.
Proud, Christopher G., et al.. (2001). Interplay between insulin and nutrients in the regulation of translation factors. Biochemical Society Transactions. 29(4). 541–547. 43 indexed citations
13.
Kleijn, Miranda & Christopher G. Proud. (2000). The activation of eukaryotic initiation factor (eIF)2B by growth factors in PC12 cells requires MEK/ERK signalling. FEBS Letters. 476(3). 262–265. 20 indexed citations
14.
Kleijn, Miranda & Christopher G. Proud. (2000). Glucose and amino acids modulate translation factor activation by growth factors in PC12 cells. Biochemical Journal. 347(2). 399–399. 33 indexed citations
15.
Kleijn, Miranda, Gavin I. Welsh, Gert C. Scheper, et al.. (1998). Nerve and Epidermal Growth Factor Induce Protein Synthesis and eIF2B Activation in PC12 Cells. Journal of Biological Chemistry. 273(10). 5536–5541. 54 indexed citations
16.
Kleijn, Miranda, et al.. (1998). Regulation of translation initiation factors by signal transduction. European Journal of Biochemistry. 253(3). 531–544. 166 indexed citations
17.
Scheper, Gert C., et al.. (1997). Inactivation of eIF2B and Phosphorylation of PHAS-I in Heat-shocked Rat Hepatoma Cells. Journal of Biological Chemistry. 272(43). 26850–26856. 47 indexed citations
18.
Kleijn, Miranda, et al.. (1996). Phosphorylation of the eIF4E‐binding protein PHAS‐I after exposure of PC12 cells to EGF and NGF. FEBS Letters. 396(2-3). 165–171. 23 indexed citations
19.
Kleijn, Miranda, Carlos L.J. Vrins, Harry O. Voorma, & Adri A.M. Thomas. (1996). Phosphorylation State of the Cap-Binding Protein eIF4E during Viral Infection. Virology. 217(2). 486–494. 40 indexed citations
20.
Kleijn, Miranda, Harry O. Voorma, & Adri A.M. Thomas. (1995). Phosphorylation of elF‐4E and initiation of protein synthesis in P19 embryonal carcinoma cells. Journal of Cellular Biochemistry. 59(4). 443–452. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ziyou Cui Breakdown of academic impact, for papers by Gerard C.M. van der Zon Breakdown of academic impact, for papers by Maria Buxadé Breakdown of academic impact, for papers by Jae Ryoung Hwang Breakdown of academic impact, for papers by Yoon Ha Choi Breakdown of academic impact, for papers by Valentina Iadevaia Breakdown of academic impact, for papers by Xianming Kong Breakdown of academic impact, for papers by Daniel DiSepio Breakdown of academic impact, for papers by Sabine Wolter Breakdown of academic impact, for papers by J. Guhaniyogi
Rankless by CCL
2026